0001062993-23-019386.txt : 20231016
0001062993-23-019386.hdr.sgml : 20231016
20231016165906
ACCESSION NUMBER: 0001062993-23-019386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231014
FILED AS OF DATE: 20231016
DATE AS OF CHANGE: 20231016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCourt Janice
CENTRAL INDEX KEY: 0001953540
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 231327806
MAIL ADDRESS:
STREET 1: C/O COMERA LIFE SCIENCES HOLDINGS, INC.
STREET 2: 12 GILL STREET, SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-10-14
1
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001953540
McCourt Janice
C/O COMERA LIFE SCIENCES HOLDINGS, INC.
12 GILL STREET, SUITE 4650
WOBURN
MA
01801
0
1
0
0
Chief Business Officer
0
Stock Option (Right to Purchase)
0.29
2023-10-14
4
A
0
20000
0
A
2023-10-14
2026-10-04
Common Stock
20000
20000
D
On October 4, 2023, the reporting person was granted an option to purchase 20,000 shares of common stock of the issuer. The option vested in full following the satisfaction of certain performance criteria including the execution of a separation agreement and release by the reporting person and the expiration of a seven-day revocation period without the reporting person revoking the separation agreement and release.
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
2023-10-16